Cartesian Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2015 to Q1 2024.
  • Cartesian Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Cartesian Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $2.03M, a 35.3% decline year-over-year.
  • Cartesian Therapeutics, Inc. annual Interest Expense for 2023 was $2.83M, a 6.53% decline from 2022.
  • Cartesian Therapeutics, Inc. annual Interest Expense for 2022 was $3.03M, a 6.58% increase from 2021.
  • Cartesian Therapeutics, Inc. annual Interest Expense for 2021 was $2.84M, a 82.8% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.03M $0 -$808K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.83M $0 -$807K -100% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $3.64M $1.27M +$471K +58.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.17M $752K +$37K +5.18% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-17
Q1 2023 $3.13M $808K +$101K +14.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $3.03M $807K +$96K +13.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $2.94M $802K +$91K +12.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.84M $715K +$4K +0.56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-17
Q1 2022 $2.84M $707K -$4K -0.56% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $2.84M $711K -$2K -0.28% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 $2.85M $711K +$346K +94.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.5M $711K +$506K +247% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.99M $711K +$438K +160% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.56M $713K +$378K +113% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 $1.18M $365K -$23K -5.93% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.2M $205K -$195K -48.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.4M $273K -$123K -31.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $1.52M $335K -$60K -15.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $1.58M $388K +$4K +1.04% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.58M $400K +$35K +9.59% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.54M $396K +$46K +13.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.49M $395K +$36K +10% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $1.46M $384K +$116K +43.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $1.34M $365K +$86K +30.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.26M $350K +$50K +16.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.21M $359K +$37K +11.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $1.17M $268K -$43K -13.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.21M $279K -$31K -10% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $1.24M $300K -$10K -3.23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $1.25M $322K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $311K -$23K -6.89% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $310K -$20K -6.06% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $310K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q3 2015 $334K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $330K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.